Cassava Sciences Announces Conference Call for Second Quarter Financial Results
- Call-in on Tuesday, August 3rd at 9 a.m. ET -
August 02, 2021 19:54 ET | Source: Cassava Sciences, Inc. Cassava Sciences, Inc. Austin, Texas, UNITED STATES
AUSTIN, Texas, Aug. 02, 2021 (GLOBE NEWSWIRE) Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, will release financial results for the period ending June 30, 2021 on Tuesday, August 3, 2021 before the market opens, followed by a conference call.
Remi Barbier, President & CEO, and Eric Schoen, Chief Financial Officer, will host a conference call to review financial results and to preview the Company’s growth strategy.
Texas
United-states
Remi-barbier
Eric-schoen
Alzheimer-disease-international
Cassava-sciences-inc
Toll-international
Cassava-sciences
Nasdaq
Chief-financial-officer
Event-click
Join-link